Cutter & Co Brokerage’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-100
| Closed | -$74K | – | 279 |
|
|
2017
Q4 | $74K | Buy |
100
+3
| +3% | +$2.22K | 0.03% | 244 |
|
|
2017
Q3 | $28K | Sell |
97
-15
| -13% | -$4.33K | 0.01% | 259 |
|
|
2017
Q2 | $29K | Hold |
112
| – | – | 0.01% | 270 |
|
|
2017
Q1 | $37K | Sell |
112
-4
| -3% | -$1.32K | 0.02% | 257 |
|
|
2016
Q4 | $69K | Buy |
116
+1
| +0.9% | +$595 | 0.03% | 237 |
|
|
2016
Q3 | $130K | Sell |
115
-4
| -3% | -$4.52K | 0.06% | 215 |
|
|
2016
Q2 | $130K | Hold |
119
| – | – | 0.06% | 212 |
|
|
2016
Q1 | $153K | Hold |
119
| – | – | 0.07% | 209 |
|
|
2015
Q4 | $292K | Sell |
119
-14
| -11% | -$34.4K | 0.14% | 141 |
|
|
2015
Q3 | $147K | Sell |
133
-15
| -10% | -$16.6K | 0.07% | 183 |
|
|
2015
Q2 | $149K | Buy |
148
+25
| +20% | +$25.2K | 0.06% | 223 |
|
|
2015
Q1 | $125K | Buy |
123
+85
| +224% | +$86.4K | 0.05% | 204 |
|
|
2014
Q4 | $125K | Buy |
+38
| New | +$125K | 0.05% | 233 |
|